Health Intervention and Technology Assessment Program (HITAP), 6th Floor, 6th Building, Department of Health, Ministry of Public Health, Tiwanon Road, Nonthaburi, 11000, Thailand.
Health Intervention and Technology Assessment Program (HITAP), 6th Floor, 6th Building, Department of Health, Ministry of Public Health, Tiwanon Road, Nonthaburi, 11000, Thailand.
Travel Med Infect Dis. 2022 Jul-Aug;48:102358. doi: 10.1016/j.tmaid.2022.102358. Epub 2022 May 18.
There are ongoing calls to harmonise and increase the use of COVID-19 vaccination certificates (CVCs) in Asia. Identifying groups in Asian societies who oppose CVCs and understanding their reasons can help formulate an effective CVCs policy in the region. However, no formal studies have explored this issue in Asia.
The COVID-19 Vaccination Policy Research and Decision-Support Initiative in Asia (CORESIA) was established to address policy questions related to CVCs. An online cross-sectional survey was conducted from June to October 2021 in nine Asian countries. Multivariable logistical regression analyses were performed to identify potential opposers of CVCs.
Six groups were identified as potential opposers of CVCs: (i) unvaccinated (Odd Ratio (OR): 2.01, 95% Confidence Interval (CI): 1.65-2.46); vaccine hesitant and those without access to COVID-19 vaccines; (ii) those not wanting existing NPIs to continue (OR: 2.97, 95% CI: 2.51-3.53); (iii) those with low level of trust in governments (OR: 1.25, 95% CI: 1.02-2.52); (iv) those without travel plans (OR: 1.58, 95% CI: 1.31-1.90); (v) those expecting no financial gains from CVCs (OR: 2.35, 95% CI: 1.98-2.78); and (vi) those disagreeing to use CVCs for employment, education, events, hospitality, and domestic travel.
Addressing recurring public health bottlenecks such as vaccine hesitancy and equitable access, adherence to policies, public trust, and changing the narrative from 'societal-benefit' to 'personal-benefit' may be necessary and may help increase wider adoption of CVCs in Asia.
亚洲各地呼吁协调并增加使用 COVID-19 疫苗接种证书(CVC)。了解亚洲社会中反对 CVC 的群体及其原因,有助于制定该地区有效的 CVC 政策。然而,目前在亚洲尚无正式研究探讨这一问题。
为解决与 CVC 相关的政策问题,成立了亚洲 COVID-19 疫苗接种政策研究与决策支持倡议(CORESIA)。2021 年 6 月至 10 月,在亚洲 9 个国家进行了一项在线横断面调查。采用多变量逻辑回归分析确定 CVC 的潜在反对者。
确定了 6 个可能反对 CVC 的群体:(i)未接种疫苗者(比值比(OR):2.01,95%置信区间(CI):1.65-2.46);疫苗犹豫者和无法获得 COVID-19 疫苗者;(ii)那些不希望继续实施现有非药物干预措施的人(OR:2.97,95%CI:2.51-3.53);(iii)对政府信任度低的人(OR:1.25,95%CI:1.02-2.52);(iv)没有旅行计划的人(OR:1.58,95%CI:1.31-1.90);(v)不期望从 CVC 中获得经济利益的人(OR:2.35,95%CI:1.98-2.78);以及(vi)不同意将 CVC 用于就业、教育、活动、酒店和国内旅行的人。
解决疫苗犹豫和公平获取等反复出现的公共卫生瓶颈问题,坚持政策,提高公众信任度,将叙事从“社会效益”转变为“个人效益”,可能是必要的,有助于在亚洲更广泛地采用 CVC。